H.I.S. Co., Ltd. Logo

H.I.S. Co., Ltd.

A major Japanese travel agency providing global tour packages, lodging, and transport.

9603 | T

Overview

Corporate Details

ISIN(s):
JP3160740001
LEI:
Country:
Japan
Address:
港区虎ノ門四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

H.I.S. Co., Ltd. is a major Japanese travel agency established in 1980. The company initially distinguished itself by pioneering the sale of low-cost airline tickets in Japan. Its primary operations involve providing a wide range of travel services, including domestic and international tour packages, lodging, and transportation solutions. The H.I.S. Group has expanded its business portfolio to include hotel operations, regional revitalization projects, and specialized inbound tourism services. With a global network, it is recognized as one of Japan's leading travel organizations, catering to a diverse clientele worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 08:36
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-13 08:34
Interim Report
半期報告書-第45期(2024/11/01-2025/10/31)
Japanese 247.2 KB
2025-06-05 10:02
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-05-23 08:31
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-05-20 09:21
M&A Activity
臨時報告書
Japanese 19.7 KB
2025-04-30 08:32
Regulatory News Service
臨時報告書
Japanese 19.8 KB
2025-03-31 10:14
Legal Proceedings Report
臨時報告書
Japanese 21.7 KB
2025-03-31 10:05
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-03-31 09:57
Governance Information
内部統制報告書-第44期(2023/11/01-2024/10/31)
Japanese 44.9 KB
2025-03-31 09:56
Registration Form
確認書
Japanese 8.1 KB
2025-03-31 09:55
Annual Report
有価証券報告書-第44期(2023/11/01-2024/10/31)
Japanese 2.1 MB
2025-03-31 09:40
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:39
Quarterly Report
訂正四半期報告書-第44期第2四半期(2024/02/01-2024/04/30)
Japanese 305.5 KB
2025-03-31 09:38
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:37
Quarterly Report
訂正四半期報告書-第44期第1四半期(2023/11/01-2024/01/31)
Japanese 249.1 KB

Automate Your Workflow. Get a real-time feed of all H.I.S. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for H.I.S. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for H.I.S. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA

Talk to a Data Expert

Have a question? We'll get back to you promptly.